BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15211470)

  • 1. Blinded review of papanicolaou smears.
    Frable WJ
    Cancer; 2004 Jun; 102(3):133-5. PubMed ID: 15211470
    [No Abstract]   [Full Text] [Related]  

  • 2. Blinded review of Papanicolaou smears in the context of litigation.
    Renshaw AA; Young ML; Holladay EB
    Cancer; 2004 Jun; 102(3):136-41. PubMed ID: 15211471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blinded review of Papanicolaou smears.
    Gill GW
    Cancer; 2005 Apr; 105(2):53-5. PubMed ID: 15662699
    [No Abstract]   [Full Text] [Related]  

  • 4. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality and liability issues with the Papanicolaou smear: the problem of definition of errors and false-negative smears.
    Davey DD
    Arch Pathol Lab Med; 1997 Mar; 121(3):267-9. PubMed ID: 9111115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Litigation cells" in the Papanicolaou smear: extramural review of smears by "experts".
    Frable WJ
    Arch Pathol Lab Med; 1997 Mar; 121(3):292-5. PubMed ID: 9111121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common problems in Papanicolaou smear interpretation.
    DeMay RM
    Arch Pathol Lab Med; 1997 Mar; 121(3):229-38. PubMed ID: 9111106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cervical smears unsuitable for exclusion of cervical carcinoma].
    Giard RW; Blok P
    Ned Tijdschr Geneeskd; 2000 Jan; 144(2):86-7. PubMed ID: 10674109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitfalls in diagnostic cervicovaginal cytology.
    Sidawy MK; Solomon D
    Monogr Pathol; 1997; (39):1-15. PubMed ID: 9249817
    [No Abstract]   [Full Text] [Related]  

  • 10. A look at Pap test accuracy and the duty to inform from a risk management perspective.
    Meister S
    QRC Advis; 1997 Dec; 14(2):1, 5-8. PubMed ID: 10176015
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency and outcome of cervical cancer prevention failures in the United States.
    Raab SS; Grzybicki DM; Zarbo RJ; Jensen C; Geyer SJ; Janosky JE; Meier FA; Vrbin CM; Carter G; Geisinger KR
    Am J Clin Pathol; 2007 Nov; 128(5):817-24. PubMed ID: 17951205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The false-negative fraction for Papanicolaou smears: how often are "abnormal" smears not detected by a "standard" screening cytologist?
    Naryshkin S
    Arch Pathol Lab Med; 1997 Mar; 121(3):270-2. PubMed ID: 9111116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Despite potential flaws, the false-negative proportion remains the best practical measure of the accuracy of cervical cytology screening.
    Krieger P; Naryshkin S
    Cancer; 1997 Oct; 81(5):261-3. PubMed ID: 9349511
    [No Abstract]   [Full Text] [Related]  

  • 14. Liability issues with the Papanicolaou smear: a defense lawyer's perspective.
    Varner CD
    Arch Pathol Lab Med; 1997 Mar; 121(3):315-20. PubMed ID: 9111126
    [No Abstract]   [Full Text] [Related]  

  • 15. HPV testing in liquid specimens.
    Geyer SJ
    Acta Cytol; 2006; 50(5):599-600. PubMed ID: 17017457
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quality of vaginal smear for cervical cancer screening: a concordance study].
    Cendales R; Wiesner C; Murillo RH; Piñeros M; Tovar S; Mejía JC
    Biomedica; 2010; 30(1):107-15. PubMed ID: 20890555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting high-risk human papillomavirus in liquid-based cytology specimens.
    Qureshi MN
    Acta Cytol; 2005; 49(5):582. PubMed ID: 16334042
    [No Abstract]   [Full Text] [Related]  

  • 18. Malpractice protection: communication of diagnostic uncertainty.
    Skoumal SM; Florell SR; Bydalek MK; Hunter WJ
    Diagn Cytopathol; 1996 Jun; 14(4):385-9. PubMed ID: 8725143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should adequacy of liquid-based cytology be defined?
    Desai M; Herbert A
    Cytopathology; 2006 Aug; 17(4):165-7. PubMed ID: 16879262
    [No Abstract]   [Full Text] [Related]  

  • 20. Reducing the error rate in Papanicolaou smears. One laboratory's experience with the PAPNET system.
    Koss LG
    Physician Assist; 1994 Dec; 18(12):48-52. PubMed ID: 10139375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.